嘉实中证疫苗与生物技术ETF(562860)资产负债表
| |
2024-12-31 |
2024-06-30 |
2023-12-31 |
2023-06-30 |
| 资产 |
| 银行存款 |
- |
- |
- |
7,304,987.73 |
| 结算备付金 |
109,305.80 |
12,123.21 |
125,407.47 |
262,404.37 |
| 存出保证金 |
16,867.02 |
12,957.55 |
47,992.36 |
476,924.95 |
| 交易性金融资产 |
288,953,460.11 |
295,334,044.64 |
490,482,438.09 |
655,463,954.15 |
| 其中：股票投资 |
288,953,460.11 |
295,334,044.64 |
490,482,438.09 |
655,463,954.15 |
| 债券投资 |
- |
- |
- |
- |
| 资产支持证券投资 |
- |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
- |
| 买入返售金融资产 |
- |
- |
- |
- |
| 应收证券清算款 |
- |
683,574.26 |
7,334.54 |
858,180.56 |
| 应收利息 |
- |
- |
- |
- |
| 应收股利 |
- |
- |
- |
- |
| 应收申购款 |
- |
- |
- |
- |
| 其他资产 |
- |
- |
26,532.99 |
- |
| 资产总计 |
292,833,452.44 |
300,312,099.27 |
495,946,132.65 |
664,366,451.76 |
| 负 债 |
| 短期借款 |
- |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
- |
| 卖出回购金融资产款 |
- |
- |
- |
- |
| 应付证券清算款 |
80,947.69 |
544,290.89 |
- |
963,192.40 |
| 应付赎回款 |
- |
- |
- |
- |
| 应付管理人报酬 |
132,038.29 |
129,693.19 |
211,779.42 |
285,721.27 |
| 应付托管费 |
26,407.65 |
25,938.66 |
42,355.87 |
57,144.25 |
| 应付销售服务费 |
- |
- |
- |
- |
| 应付交易费用 |
- |
- |
- |
- |
| 应交税费 |
- |
- |
2,711.81 |
- |
| 应付利息 |
- |
- |
- |
- |
| 应付利润 |
- |
- |
- |
- |
| 其他负债 |
158,423.41 |
122,973.29 |
283,487.23 |
249,166.73 |
| 负债合计 |
397,817.04 |
822,896.03 |
540,334.33 |
1,555,224.65 |
| 所有者权益 |
| 实收基金 |
480,894,966.00 |
520,894,966.00 |
590,894,966.00 |
826,894,966.00 |
| 未分配利润 |
-188,459,330.60 |
-221,405,762.76 |
-95,489,167.68 |
-164,083,738.89 |
| 所有者权益合计 |
292,435,635.40 |
299,489,203.24 |
495,405,798.32 |
662,811,227.11 |
| 负债及所有者权益总计 |
292,833,452.44 |
300,312,099.27 |
495,946,132.65 |
664,366,451.76 |
微信公众号
证券之星APP
基本资料
